CD20 expression in B-cell precursor acute lymphoblastic leukemia is common in Mexican patients and lacks a prognostic value

Figures & data

Table 1. Salient features according to CD20 expression in 143 patients with precursor B-cell ALL

	<16 years		P value	≥16 years		P value
	CD20+	CD20−		CD20+	CD20−
Patients	58	35		25	21
Age median	8	6	0.15	30	37	0.23
Range	1–15	1–15
Males (%)	39 (67)	12	0.003	15	11	0.7
WBCx109/l median	8.3	9.4	0.97	26	16	0.34
Range	0.60–100	1–61		1.8–400	1–230
Philadelphia chromosome positive	4	0	0.13	6	4	0.7
Negative MRD (%)	33 (39)	21 (61)	0.83	14	17	0.11
Positive MRD	25 (64)	14 (36)		11	7

Figure 1. CIR and OS according to CD20 expression in children.

Figure 2. CIR and OS according to CD20 expression in adults.